ExcellENT programme: Enterprise education workshops for healthcare & life sciences research launched
January 2010
The Enterprise Office, in partnership with IPSO Ventures, has launched the second series of workshops in its ExcellENT Programme which will focus on healthcare & life sciences and medical technology research.
The Programme, initially launched in October last year, provides research staff and students with the opportunity to learn from leading entrepreneurs and business experts about how best to bridge the industry-academia divide and translate their research to meet market demand.
The Programme stages interactive workshops for small groups, alongside providing opportunities to be mentored by leading entrepreneurs. The first set of workshops covered the areas of electronic engineering and computer science and were very well received. Pete Magowan, a highly experienced entrepreneur and investor in the software and microchip sectors, met with researchers to discuss new inventions and applications of their work, plus discussing the commercialisation of existing opportunities and possibilities for collaboration with his industry contacts.
We can now announce the second series - for researchers working in healthcare-related areas - which will take place at 11am in the Innovation Cetnre on the following dates:
Friday 22 January
Friday 29 January
Friday 5 February
Friday 19 February
Friday 26 February
To book a place on one of the workshops or to talk to someone about the Programme, contact:
Tim Carter: 020 7921 2990, or
Jason Wiggins: 01509 223437
Our ‘resident’ Entrepreneur for this phase of the programme is Tim Clover, CEO of Moonray Healthcare, the biomedical technology investment vehicle of Fidelity International.
Tim brings with him twenty years of experience within the medical and pharmaceutical industry. Before joining Moonray, Tim was CEO of T+ Medical Holdings Ltd., a private international medical technology company specialising in remote patient management and electronic clinical trials. Prior to this he was Vice President (Europe, Middle East and Africa) for eyecare with Allergan Inc., a multi-speciality healthcare company, before founding Advanced Medical Optics Inc. which spun off from Allergan in 2002. AMO Inc. grew into a leading medical device company focusing on the discovery and delivery of innovative vision technologies, operating internationally with sales in excess of $1bn and publicly quoted on the NYSE. Tim will be in attendance at the first of the workshops on 22nd January and will be available at other times to meet with researchers to discuss their work.